ARS Pharmaceuticals, Inc. Common Stock SPRY
$5.62
-0.88%
at last close
Analyst Consensus
- Consensus Rating
- Buy (2 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $27.00
- Implied Upside
- +380.4%
- Price Target Range
- $24.00 – $30.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-25 | Leerink PartnersRoanna Ruiz |
Maintains | Outperform | $25 → $24 |
| 2026-05-28 | Cantor FitzgeraldJosh Schimmer |
Maintains | Overweight | $12 → $30 |
| 2025-09-04 | Roth CapitalJason Wittes |
Initiates coverage on | Buy | $40 |
| 2025-03-07 | ScotiabankLouise Chen |
Initiates coverage on | Sector outperform | $30 |
| 2025-01-14 | Raymond JamesRyan Deschner |
Maintains | Strong buy | $26 → $28 |
| 2025-01-13 | Leerink PartnersRoanna Ruiz |
Maintains | Outperform | $26 → $27 |
| 2024-10-08 | Cantor FitzgeraldJosh Schimmer |
Reiterates | Overweight | $30 |
| 2024-09-20 | Leerink PartnersRoanna Ruiz |
Maintains | Outperform | $21 → $25 |
| 2024-09-16 | Cantor FitzgeraldJosh Schimmer |
Reiterates | Overweight | $30 |
| 2024-09-09 | Cantor FitzgeraldJosh Schimmer |
Reiterates | Overweight | $30 |
| 2024-08-20 | Cantor FitzgeraldJosh Schimmer |
Initiates coverage on | Overweight | $30 |
| 2024-08-13 | Raymond JamesRyan Deschner |
Upgrades | Outperform → Strong buy | $18 → $22 |
| 2024-07-25 | Raymond JamesRyan Deschner |
Initiates coverage on | Outperform | $18 |
| 2024-03-11 | WedbushAndreas Argyrides |
Reiterates | Outperform | $19 |
| 2024-03-05 | Leerink PartnersRoanna Ruiz |
Upgrades | Market perform → Outperform | $6 → $18 |
| 2023-11-13 | WedbushAndreas Argyrides |
Maintains | Outperform | $5 → $13 |
| 2023-09-21 | WedbushAndreas Argyrides |
Maintains | Outperform | $15 → $5 |
| 2023-09-20 | William BlairTim Lugo |
Downgrades | Outperform → Market perform | — |
| 2023-08-14 | WedbushAndreas Argyrides |
Reiterates | Outperform | $15 |
| 2023-06-21 | WedbushAndreas Argyrides |
Maintains | Outperform | $17 → $15 |
| 2023-05-18 | WedbushAndreas Argyrides |
Reiterates | Outperform | $17 |
| 2023-05-12 | WedbushAndreas Argyrides |
Reiterates | Outperform | $17 |
| 2023-05-10 | WedbushAndreas Argyrides |
Reiterates | Outperform | $17 |
| 2023-01-31 | WedbushAndreas Argyrides |
Initiates coverage on | Outperform | $10 |
| 2023-01-04 | William BlairTim Lugo |
Initiates coverage on | Outperform | — |
| 2022-12-13 | SVB LeerinkRoanna Ruiz |
Initiates coverage on | Outperform | $14 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.62
- Market Cap
- $558.89 million
- 52-Week Range
- $4.91 – $18.00
- Average Volume
- 1.90 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.